World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21218
World Ranking
17639
National Ranking
8810

Pamela K. Allen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pamela K. Allen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 449 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pamela K. Allen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pamela K. Allen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pamela K. Allen is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Pulmonary and Respiratory Medicine, Genetics, Oncology, Radiology, Nuclear Medicine and Imaging, and Surgery.

The main topics covered in their work involve:

  • Glioma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Radiation Therapy and Dosimetry

Allen's recent published papers include the following:

  • Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database, 2020, Scientific Reports
  • Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer, 2020, Head & Neck
  • Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy, 2020, Radiotherapy and Oncology
  • Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure, 2020, Radiotherapy and Oncology
  • Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial, 2020, International Journal of Radiation Oncology*Biology*Physics

The frequent publication venues in which Allen has contributed articles are:

  • International Journal of Radiation Oncology*Biology*Physics
  • Clinical Lymphoma Myeloma & Leukemia
  • Radiotherapy and Oncology
  • Clinical Lung Cancer
  • JAAD Case Reports

Notable frequent co-authors include:

  • Zhongxing Liao
  • Joe Y. Chang
  • Dario Pasalic
  • Bhavana V. Chapman
  • Amol J. Ghia

Best Publications

  • Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

    Eric L Chang;Jeffrey S Wefel;Kenneth R Hess;Pamela K Allen

  • Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

    Nora A Janjan;Vincent S Khoo;James Abbruzzese;Richard Pazdur

  • Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure

    Eric L. Chang;Almon S. Shiu;Ehud Mendel;Leni A. Mathews

  • Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer

    James Welsh;Ritsuko Komaki;Arya Amini;Mark F. Munsell

  • [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

    Ryohei Sasaki;Ritsuko Komaki;Homer Macapinlac;Jeremy Erasmus

  • Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.

    Nora A. Janjan;Christopher Crane;Barry W. Feig;Karen Cleary

  • Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

    Zhongxing Liao;J. Jack Lee;Ritsuko Komaki;Daniel R. Gomez

  • Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial

    Xin Shelley Wang;Laurence D Rhines;Almon S Shiu;James N Yang

  • Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients With Cancer According to Insurance Status

    Gary V. Walker;Stephen R. Grant;B. Ashleigh Guadagnolo;Karen E. Hoffman

  • Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases

    Nicholas S. Boehling;David R. Grosshans;Pamela K. Allen;Mary F. McAleer

  • Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a “No Fly Zone”

    Joe Y Chang;Qiao Qiao Li;Qing Yong Xu;Pamela K. Allen

  • Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.

    Eric L. Chang;Serap Akyurek;Tedde Avalos;Neal Rebueno

  • Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trial

    Ritsuko Komaki;Jin Soo Lee;Luka Milas;Hoon K. Lee

  • Phase 1/2 Trial of Single-Session Stereotactic Body Radiotherapy for Previously Unirradiated Spinal Metastases

    Amit K. Garg;Almon S. Shiu;James Yang;Xin Shelley Wang

  • Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

    Joe Y. Chang;Ritsuko Komaki;Charles Lu;Hong Y. Wen

  • MANAGEMENT OF SPINAL METASTASES FROM RENAL CELL CARCINOMA USING STEREOTACTIC BODY RADIOTHERAPY

    Quynh Nhu Nguyen;Almon S. Shiu;Laurence D. Rhines;He Wang

  • Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.

    Serap Akyurek;Serap Akyurek;Eric L. Chang;Tse Kuan Yu;Darrin Little

  • Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

    Nora A Janjan;James Abbruzzese;Richard Pazdur;Vincent S Khoo

  • Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases

    Ugur Selek;Eric L. Chang;Samuel J. Hassenbusch;Almon S. Shiu

  • Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience.

    Amit K. Garg;Xin Shelley Wang;Almon S. Shiu;Pamela Allen

Frequent Co-Authors

Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Joe Y. Chang
Joe Y. Chang The University of Texas MD Anderson Cancer Center
Paul D. Brown
Paul D. Brown Mayo Clinic
Thomas A. Buchholz
Thomas A. Buchholz The University of Texas MD Anderson Cancer Center
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Wendy A. Woodward
Wendy A. Woodward The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA can open doors to a range of respected healthcare careers beyond the traditional MD route. Many students consider nursing as a flexible and rewarding pathway, with numerous accredited programs now available online.

If you’re looking for budget-friendly options, you can review some most affordable nurse practitioner programs or find affordable nursing programs well suited for students balancing work and study.

Nurses seeking to advance their career can also consider the online phd programs in nursing to move into research or leadership roles. For registered nurses aiming to upgrade their credentials, the cheapest online rn to bsn programs offer an efficient and cost-effective path.

Exploring these online degrees can greatly expand your opportunities within the rapidly growing healthcare sector while keeping your educational expenses manageable.

Best Scientists Citing Pamela K. Allen

Trending Scientists

Recently Published Articles